- Home
- Publications
- Publication Search
- Publication Details
Title
Tim-3 and Tim-4 as the potential targets for antitumor therapy
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 10, Pages 2458-2462
Publisher
Informa UK Limited
Online
2015-07-25
DOI
10.1080/21645515.2015.1056953
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
- (2015) Gordon J. Freeman et al. IMMUNOLOGICAL REVIEWS
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L
- (2014) M C Ramello et al. Cell Death & Disease
- RepSox Slows Decay of CD34+Acute Myeloid Leukemia Cells and Decreases T Cell Immunoglobulin Mucin-3 Expression
- (2014) Audrey N. Jajosky et al. Stem Cells Translational Medicine
- Reversal of NK-Cell Exhaustion in Advanced Melanoma by Tim-3 Blockade
- (2014) I. P. da Silva et al. Cancer Immunology Research
- The T-cell immunoglobulin and mucin domain (Tim) gene family in asthma, allergy, and autoimmunity
- (2013) Zhenhong Li et al. ALLERGY AND ASTHMA PROCEEDINGS
- Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer
- (2013) Yong-Rui Piao et al. Asian Pacific Journal of Cancer Prevention
- PD-1 and Tim-3 Regulate the Expansion of Tumor Antigen-Specific CD8+ T Cells Induced by Melanoma Vaccines
- (2013) J. Fourcade et al. CANCER RESEARCH
- The Expression of Tim-3 in Peripheral Blood of Ovarian Cancer
- (2013) Jie Wu et al. DNA AND CELL BIOLOGY
- TIM-4 Glycoprotein-Mediated Degradation of Dying Tumor Cells by Autophagy Leads to Reduced Antigen Presentation and Increased Immune Tolerance
- (2013) Muhammad Baghdadi et al. IMMUNITY
- Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
- (2013) Zhu Li et al. INFECTION GENETICS AND EVOLUTION
- TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells
- (2013) Yoshikane Kikushige et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
- (2013) Zhiqiang Guo et al. Journal of Translational Medicine
- Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis
- (2013) Yang Cao et al. PLoS One
- Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer
- (2013) Jing Jiang et al. PLoS One
- T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer
- (2013) Jianwen Bai et al. TUMOR BIOLOGY
- Ectopic Expression of TIM-3 in Lung Cancers
- (2012) Xuewei Zhuang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- TIM-3 as a therapeutic target for malignant stem cells in acute myelogenous leukemia
- (2012) Yoshikane Kikushige et al. Annals of the New York Academy of Sciences
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas
- (2012) Muhammad Baghdadi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- T-Cell Immunoglobulin- and Mucin-Domain-Containing Molecule 3 Gene Polymorphisms and Renal Cell Carcinoma
- (2012) Chen Cai et al. DNA AND CELL BIOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- T cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and susceptibility to pancreatic cancer
- (2012) Danian Tong et al. MOLECULAR BIOLOGY REPORTS
- Tumor immunity times out: TIM-3 and HMGB1
- (2012) Daolin Tang et al. NATURE IMMUNOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- CD8+ T Cells Specific for Tumor Antigens Can Be Rendered Dysfunctional by the Tumor Microenvironment through Upregulation of the Inhibitory Receptors BTLA and PD-1
- (2011) J. Fourcade et al. CANCER RESEARCH
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer
- (2010) Bangwei Cao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
- (2010) Yoshikane Kikushige et al. Cell Stem Cell
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice
- (2010) R. Rodriguez-Manzanet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
- (2009) Jennifer S. Carew et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization
- (2008) M. A. Qadir et al. BREAST CANCER RESEARCH AND TREATMENT
- Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy
- (2008) A. Apel et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More